Transcriptome Sequencing of Gene Expression in the Brain of the HIV-1 Transgenic Rat

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Li, Ming D ^a   Cao, Junran ^a   Wang, Shaolin ^a,b   Wang, Ju ^a   Sarkar, Sraboni ^c   Vigorito, Michael ^c   Ma, Jennie Z ^d   Chang, Sulie L ^c  

^a UNIVERSITY OF VIRGINIA   (United States)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c SETON HALL UNIVERSITY   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; GROWTH FACTOR; MYELIN PROTEIN; POL PROTEIN; TRANSCRIPTOME; VIRUS RNA;

ANIMAL TISSUE; ARTICLE; BRAIN REGION; CELL SURVIVAL; CONTROLLED STUDY; CORPUS STRIATUM; DRUG DEPENDENCE; EXON; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE MAPPING; GENOME ANALYSIS; HIPPOCAMPUS; HIV ASSOCIATED DEMENTIA; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; LEARNING DISORDER; MALE; MEMORY DISORDER; MENTAL DISEASE; NEUROTRANSMISSION; NONHUMAN; PREFRONTAL CORTEX; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; STRUCTURAL GENE; TRANSGENIC RAT; UPREGULATION; VIRUS GENOME;

ANIMALS; BRAIN; COMPUTATIONAL BIOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HIV-1; HUMANS; MALE; MOLECULAR SEQUENCE ANNOTATION; RATS; RATS, TRANSGENIC; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TRANSCRIPTOME;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS 1; RATTUS;

EID: 84875430753     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059582     Document Type: Article

References (96)

1. Cicala C, Arthos J, Selig SM, Dennis G Jr, Hosack DA, et al. (2002) HIV envelope induces a cascade of cell signals in non-proliferating target cells that favor virus replication. Proc Natl Acad Sci U S A 99: 9380-9385.
2. Torensma R, Figdor CG, (2002) The Achilles' heel of HIV. Medical Hypotheses 58: 386-387.
3. Verani A, Gras G, Pancino G, (2005) Macrophages and HIV-1: dangerous liaisons. Molecular Immunology 42: 195-212.
4. Trkola A, (2004) HIV-host interactions: vital to the virus and key to its inhibition. Curr Opin Microbiol 7: 555-559.
5. Clapham PR, McKnight A, (2001) HIV-1 receptors and cell tropism. Br Med Bull 58: 43-59.
6. Jiang J, Aiken C, (2006) Maturation of the viral core enhances the fusion of HIV-1 particles with primary human T cells and monocyte-derived macrophages. Virology 346: 460-468.
7. Maragos WF, Young KL, Turchan JT, Guseva M, Pauly JR, et al. (2002) Human immunodeficiency virus-1 Tat protein and methamphetamine interact synergistically to impair striatal dopaminergic function. J Neurochem 83: 955-963.
8. Aksenov MY, Hasselrot U, Bansal AK, Wu G, Nath A, et al. (2001) Oxidative damage induced by the injection of HIV-1 Tat protein in the rat striatum. Neurosci Lett 305: 5-8.
9. Eichenbaum H, Schoenbaum G, Young B, Bunsey M, (1996) Functional organization of the hippocampal memory system. Proc Natl Acad Sci U S A 93: 13500-13507.
10. Packard MG, Knowlton BJ, (2002) Learning and memory functions of the Basal Ganglia. Annu Rev Neurosci 25: 563-593.
11. Carpenter GA, Grossberg S, (1993) Normal and amnesic learning, recognition and memory by a neural model of cortico-hippocampal interactions. Trends Neurosci 16: 131-137.
12. Wise RA, (2000) Interactions between medial prefrontal cortex and meso-limbic components of brain reward circuitry. Prog Brain Res 126: 255-262.
13. Khurdayan VK, Buch S, El-Hage N, Lutz SE, Goebel SM, et al. (2004) Preferential vulnerability of astroglia and glial precursors to combined opioid and HIV-1 Tat exposure in vitro. Eur J Neurosci 19: 3171-3182.
14. Yoshioka M, Itoyama Y, (1997) [Pathogenesis of HIV-1-associated-neurologic diseases]. Nippon Rinsho 55: 897-903.
15. Portegies P (1995) Review of antiretroviral therapy in the prevention of HIV-related AIDS dementia complex (ADC). Drugs 49 Suppl 1: 25-31; discussion 38-40.
16. Gisslen M, Svennerholm B, Fuchs D, Hagberg L, (1998) Neurological efficacy of stavudine, zidovudine, and lamivudine. Lancet 352: 402-403.
17. Gendelman HE, Zheng J, Coulter CL, Ghorpade A, Che M, et al. (1998) Suppression of inflammatory neurotoxins by highly active antiretroviral therapy in human immunodeficiency virus-associated dementia. J Infect Dis 178: 1000-1007.
18. McArthur JC, Haughey N, Gartner S, Conant K, Pardo C, et al. (2003) Human immunodeficiency virus-associated dementia: an evolving disease. J Neurovirol 9: 205-221.
19. Sleasman JW, Goodenow MM, (2003) HIV-1 infection. Journal of Allergy and Clinical Immunology 111: 582-592.
20. Vigano A, Trabattoni D, Schneider L, Ottaviani F, Aliffi A, et al. (2006) Failure to eradicate HIV despite fully successful HAART initiated in the first days of life. J Pediatr 148: 389-391.
21. Agbottah E, Zhang N, Dadgar S, Pumfery A, Wade JD, et al. (2006) Inhibition of HIV-1 virus replication using small soluble Tat peptides. Virology 345: 373-389.
22. Barbaro G, Scozzafava A, Mastrolorenzo A, Supuran CT, (2005) Highly active antiretroviral therapy: current state of the art, new agents and their pharmacological interactions useful for improving therapeutic outcome. Curr Pharm Des 11: 1805-1843.
23. Gianotti N, Lazzarin A, (2005) Sequencing antiretroviral drugs for long-lasting suppression of HIV replication. New Microbiol 28: 281-297.
24. Jones LE, Perelson AS, (2005) Opportunistic infection as a cause of transient viremia in chronically infected HIV patients under treatment with HAART. Bull Math Biol 67: 1227-1251.
25. Lucas S, (2001) Update on the pathology of AIDS. Intensive Crit Care Nurs 17: 155-166.
26. Reid W, Sadowska M, Denaro F, Rao S, Foulke J Jr, et al. (2001) An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction. Proc Natl Acad Sci U S A 98: 9271-9276.
27. Mazzucchelli R, Amadio M, Curreli S, Denaro F, Bemis K, et al. (2004) Establishment of an ex vivo model of monocytes-derived macrophages differentiated from peripheral blood mononuclear cells (PBMCs) from HIV-1 transgenic rats. Mol Immunol 41: 979-984.
28. Reid W, Abdelwahab S, Sadowska M, Huso D, Neal A, et al. (2004) HIV-1 transgenic rats develop T cell abnormalities. Virology 321: 111-119.
29. Ray PE, Liu XH, Robinson LR, Reid W, Xu L, et al. (2003) A novel HIV-1 transgenic rat model of childhood HIV-1-associated nephropathy. Kidney Int 63: 2242-2253.
30. Lashomb AL, Vigorito M, Chang SL, (2009) Further characterization of the spatial learning deficit in the human immunodeficiency virus-1 transgenic rat. J Neurovirol 15: 14-24.
31. Vigorito M, LaShomb AL, Chang SL, (2007) Spatial learning and memory in HIV-1 transgenic rats. J Neuroimmune Pharmacol 2: 319-328.
32. Homji NF, Mao X, Langsdorf EF, Chang SL, (2012) Endotoxin-induced cytokine and chemokine expression in the HIV-1 transgenic rat. J Neuroinflammation 9: 3.
33. Midde NM, Gomez AM, Harrod SB, Zhu J, (2011) Genetically expressed HIV-1 viral proteins attenuate nicotine-induced behavioral sensitization and alter mesocorticolimbic ERK and CREB signaling in rats. Pharmacol Biochem Behav 98: 587-597.
34. Sarkar S, Mao X, Liu C, Chang SL (2012) Age- and Ethanol Concentration-Dependent Effects of Acute Binge Drinking in the HIV-1 Transgenic Rat. Alcohol Clin Exp Res.
35. Paxinos G, Watson C (1998) The Rat Brain in Stereotaxic Coordinates. New York: Academic Press.
36. Wang L, Wang S, Li W, (2012) RSeQC: quality control of RNA-seq experiments. Bioinformatics 28: 2184-2185.
37. Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, et al. (2010) Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol 28: 511-515.
38. Li MD, Kane JK, Wang J, Ma JZ, (2004) Time-dependent changes in transcriptional profiles within five rat brain regions in response to nicotine treatment. Brain Res Mol Brain Res 132: 168-180.
39. Benjamini Y, Hochberg Y, (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society, Series B 57: 289-300.
40. Wei J, Wang J, Dwyer JB, Mangold J, Cao J, et al. (2011) Gestational nicotine treatment modulates cell death/survival-related pathways in the brains of adolescent female rats. Int J Neuropsychopharmacol 14: 91-106.
41. Cao J, Dwyer JB, Mangold JE, Wang J, Wei J, et al. (2011) Modulation of cell adhesion systems by prenatal nicotine exposure in limbic brain regions of adolescent female rats. Int J Neuropsychopharmacol 14: 157-174.
42. Cui WY, Wang J, Wei J, Cao J, Chang SL, et al. (2012) Modulation of innate immune-related pathways in nicotine-treated SH-SY5Y cells. Amino Acids 43: 1157-1169.
43. Wang J, Cui W, Wei J, Sun D, Gutala R, et al. (2011) Genome-wide expression analysis reveals diverse effects of acute nicotine exposure on neuronal function-related genes and pathways. Front Psychiatry 2: 5.
44. Winer J, Jung CK, Shackel I, Williams PM, (1999) Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem 270: 41-49.
45. Andersen CL, Jensen JL, Orntoft TF, (2004) Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 64: 5245-5250.
46. Royal W, 3rd, Zhang L, Guo M, Jones O, Davis H, et al (2012) Immune activation, viral gene product expression and neurotoxicity in the HIV-1 transgenic rat. J Neuroimmunol 247: 16-24.
47. Rao JS, Kim HW, Kellom M, Greenstein D, Chen M, et al. (2011) Increased neuroinflammatory and arachidonic acid cascade markers, and reduced synaptic proteins, in brain of HIV-1 transgenic rats. J Neuroinflammation 8: 101.
48. Barnes BJ, Field AE, Pitha-Rowe PM, (2003) Virus-induced heterodimer formation between IRF-5 and IRF-7 modulates assembly of the IFNA enhanceosome in vivo and transcriptional activity of IFNA genes. J Biol Chem 278: 16630-16641.
49. Ning S, Pagano JS, Barber GN, (2011) IRF7: activation, regulation, modification and function. Genes Immun 12: 399-414.
50. Liege S, Laye S, Li KS, Moze E, Neveu PJ, (2000) Interleukin 1 receptor accessory protein (IL-1RAcP) is necessary for centrally mediated neuroendocrine and immune responses to IL-1beta. J Neuroimmunol 110: 134-139.
51. Qin J, Jiang Z, Qian Y, Casanova JL, Li X, (2004) IRAK4 kinase activity is redundant for interleukin-1 (IL-1) receptor-associated kinase phosphorylation and IL-1 responsiveness. J Biol Chem 279: 26748-26753.
52. Avital A, Goshen I, Kamsler A, Segal M, Iverfeldt K, et al. (2003) Impaired interleukin-1 signaling is associated with deficits in hippocampal memory processes and neural plasticity. Hippocampus 13: 826-834.
53. Ben Menachem-Zidon O, Avital A, Ben-Menahem Y, Goshen I, Kreisel T, et al. (2011) Astrocytes support hippocampal-dependent memory and long-term potentiation via interleukin-1 signaling. Brain Behav Immun 25: 1008-1016.
54. Godefroy D, Gosselin RD, Yasutake A, Fujimura M, Combadiere C, et al. (2012) The chemokine CCL2 protects against methylmercury neurotoxicity. Toxicol Sci 125: 209-218.
55. Turbic A, Leong SY, Turnley AM, (2011) Chemokines and inflammatory mediators interact to regulate adult murine neural precursor cell proliferation, survival and differentiation. PLoS One 6: e25406.
56. Ansari AW, Heiken H, Meyer-Olson D, Schmidt RE, (2011) CCL2: a potential prognostic marker and target of anti-inflammatory strategy in HIV/AIDS pathogenesis. Eur J Immunol 41: 3412-3418.
57. Kaul M, Lipton SA, (2006) Mechanisms of neuroimmunity and neurodegeneration associated with HIV-1 infection and AIDS. J Neuroimmune Pharmacol 1: 138-151.
58. Kanno M, Suzuki S, Fujiwara T, Yokoyama A, Sakamoto A, et al. (2005) Functional expression of CCL6 by rat microglia: a possible role of CCL6 in cell-cell communication. J Neuroimmunol 167: 72-80.
59. Lauzon NM, Ahmad T, Laviolette SR (2011) Dopamine D4 Receptor Transmission in the Prefrontal Cortex Controls the Salience of Emotional Memory via Modulation of Calcium Calmodulin-Dependent Kinase II. Cereb Cortex.
60. Yuen EY, Zhong P, Yan Z, (2010) Homeostatic regulation of glutamatergic transmission by dopamine D4 receptors. Proc Natl Acad Sci U S A 107: 22308-22313.
61. Herve D, Levi-Strauss M, Marey-Semper I, Verney C, Tassin JP, et al. (1993) G(olf) and Gs in rat basal ganglia: possible involvement of G(olf) in the coupling of dopamine D1 receptor with adenylyl cyclase. J Neurosci 13: 2237-2248.
62. Zill P, Engel R, Baghai TC, Zwanzger P, Schule C, et al. (2002) Analysis of polymorphisms in the olfactory G-protein Golf in major depression. Psychiatr Genet 12: 17-22.
63. Corvol JC, Valjent E, Pascoli V, Robin A, Stipanovich A, et al. (2007) Quantitative changes in Galphaolf protein levels, but not D1 receptor, alter specifically acute responses to psychostimulants. Neuropsychopharmacology 32: 1109-1121.
64. Vuoristo JT, Berrettini WH, Overhauser J, Prockop DJ, Ferraro TN, et al. (2000) Sequence and genomic organization of the human G-protein Golfalpha gene (GNAL) on chromosome 18p11, a susceptibility region for bipolar disorder and schizophrenia. Mol Psychiatry 5: 495-501.
65. Treutlein J, Muhleisen TW, Frank J, Mattheisen M, Herms S, et al. (2009) Dissection of phenotype reveals possible association between schizophrenia and Glutamate Receptor Delta 1 (GRID1) gene promoter. Schizophr Res 111: 123-130.
66. Decaillot FM, Rozenfeld R, Gupta A, Devi LA, (2008) Cell surface targeting of mu-delta opioid receptor heterodimers by RTP4. Proc Natl Acad Sci U S A 105: 16045-16050.
67. Beuten J, Ma JZ, Payne TJ, Dupont RT, Crews KM, et al. (2005) Single- and Multilocus Allelic Variants within the GABAB Receptor Subunit 2 (GABAB2) Gene Are Significantly Associated with Nicotine Dependence. Am J Hum Genet 76: 859-864.
68. Li MD, Mangold JE, Seneviratne C, Chen GB, Ma JZ, et al. (2009) Association and interaction analyses of GABBR1 and GABBR2 with nicotine dependence in European- and African-American populations. PLoS One 4: e7055.
69. Sun D, Huang W, Hwang YY, Zhang Y, Zhang Q, et al. (2007) Regulation by nicotine of Gpr51 and Ntrk2 expression in various rat brain regions. Neuropsychopharmacology 32: 110-116.
70. Ribeiro AF, Correia D, Torres AA, Boas GR, Rueda AV, et al. (2012) A transcriptional study in mice with different ethanol-drinking profiles: possible involvement of the GABA(B) receptor. Pharmacol Biochem Behav 102: 224-232.
71. Cui WY, Seneviratne C, Gu J, Li MD, (2012) Genetics of GABAergic signaling in nicotine and alcohol dependence. Hum Genet 131: 843-855.
72. Homji NF, Vigorito M, Chang SL, (2012) Morphine-induced conditioned place preference and associated behavioural plasticity in HIV-1 transgenic rats. Int J Clin Exp Med 5: 105-123.
73. Du Y, Dreyfus CF, (2002) Oligodendrocytes as providers of growth factors. J Neurosci Res 68: 647-654.
74. Nave KA, Trapp BD, (2008) Axon-glial signaling and the glial support of axon function. Annu Rev Neurosci 31: 535-561.
75. Berger JR, Tornatore C, Major EO, Bruce J, Shapshak P, et al. (1992) Relapsing and remitting human immunodeficiency virus-associated leukoencephalomyelopathy. Ann Neurol 31: 34-38.
76. Schmidbauer M, Huemer M, Cristina S, Trabattoni GR, Budka H, (1992) Morphological spectrum, distribution and clinical correlation of white matter lesions in AIDS brains. Neuropathol Appl Neurobiol 18: 489-501.
77. Borjabad A, Morgello S, Chao W, Kim SY, Brooks AI, et al. (2011) Significant effects of antiretroviral therapy on global gene expression in brain tissues of patients with HIV-1-associated neurocognitive disorders. PLoS Pathog 7: e1002213.
78. Stenman JM, Rajagopal J, Carroll TJ, Ishibashi M, McMahon J, et al. (2008) Canonical Wnt signaling regulates organ-specific assembly and differentiation of CNS vasculature. Science 322: 1247-1250.
79. Mikels AJ, Nusse R, (2006) Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context. PLoS Biol 4: e115.
80. Kim H, Won S, Hwang DY, Lee JS, Kim M, et al. (2011) Downregulation of Wnt/beta-catenin signaling causes degeneration of hippocampal neurons in vivo. Neurobiol Aging 32: 2316 e2311-2315.
81. Tawk M, Makoukji J, Belle M, Fonte C, Trousson A, et al. (2011) Wnt/beta-catenin signaling is an essential and direct driver of myelin gene expression and myelinogenesis. J Neurosci 31: 3729-3742.
82. Toledo EM, Inestrosa NC (2010) Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1DeltaE9 mouse model of Alzheimer's disease. Mol Psychiatry 15: 272-285, 228.
83. Lin Y, Chen L, Lin C, Luo Y, Tsai RY, et al. (2009) Neuron-derived FGF9 is essential for scaffold formation of Bergmann radial fibers and migration of granule neurons in the cerebellum. Dev Biol 329: 44-54.
84. Wu QF, Yang L, Li S, Wang Q, Yuan XB, et al. (2012) Fibroblast growth factor 13 is a microtubule-stabilizing protein regulating neuronal polarization and migration. Cell 149: 1549-1564.
85. Cohen RI, Chandross KJ, (2000) Fibroblast growth factor-9 modulates the expression of myelin related proteins and multiple fibroblast growth factor receptors in developing oligodendrocytes. J Neurosci Res 61: 273-287.
86. Naruo K, Seko C, Kuroshima K, Matsutani E, Sasada R, et al. (1993) Novel secretory heparin-binding factors from human glioma cells (glia-activating factors) involved in glial cell growth. Purification and biological properties. J Biol Chem 268: 2857-2864.
87. Huang JY, Hong YT, Chuang JI, (2009) Fibroblast growth factor 9 prevents MPP+-induced death of dopaminergic neurons and is involved in melatonin neuroprotection in vivo and in vitro. J Neurochem 109: 1400-1412.
88. Richards AB, Scheel TA, Wang K, Henkemeyer M, Kromer LF, (2007) EphB1 null mice exhibit neuronal loss in substantia nigra pars reticulata and spontaneous locomotor hyperactivity. Eur J Neurosci 25: 2619-2628.
89. Hollander A, D'Onofrio PM, Magharious MM, Lysko MD, Koeberle PD, (2012) Quantitative retinal protein analysis after optic nerve transection reveals a neuroprotective role for hepatoma-derived growth factor on injured retinal ganglion cells. Invest Ophthalmol Vis Sci 53: 3973-3989.
90. Chesik D, Wilczak N, De Keyser J, (2007) The insulin-like growth factor system in multiple sclerosis. Int Rev Neurobiol 79: 203-226.
91. O'Neill C, Kiely AP, Coakley MF, Manning S, Long-Smith CM, (2012) Insulin and IGF-1 signalling: longevity, protein homoeostasis and Alzheimer's disease. Biochem Soc Trans 40: 721-727.
92. Moloney AM, Griffin RJ, Timmons S, O'Connor R, Ravid R, et al. (2010) Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling. Neurobiol Aging 31: 224-243.
93. Sui Y, Potula R, Pinson D, Adany I, Li Z, et al. (2003) Microarray analysis of cytokine and chemokine genes in the brains of macaques with SHIV-encephalitis. J Med Primatol 32: 229-239.
94. Bjorkqvist M, Ohlsson M, Minthon L, Hansson O, (2012) Evaluation of a previously suggested plasma biomarker panel to identify Alzheimer's disease. PLoS One 7: e29868.
95. Potula R, Dhillion N, Sui Y, Zien CA, Funa K, et al. (2004) Association of platelet-derived growth factor-B chain with simian human immunodeficiency virus encephalitis. Am J Pathol 165: 815-824.
96. Maggi LB Jr, Kuchenruether M, Dadey DY, Schwope RM, Grisendi S, et al. (2008) Nucleophosmin serves as a rate-limiting nuclear export chaperone for the Mammalian ribosome. Mol Cell Biol 28: 7050-7065.